ONCOCOLLAPSE Trademark

Trademark Overview


On Monday, June 29, 2020, a trademark application was filed for ONCOCOLLAPSE with the United States Patent and Trademark Office. The USPTO has given the ONCOCOLLAPSE trademark a serial number of 79292101. The federal status of this trademark filing is REGISTERED as of Tuesday, May 11, 2021. This trademark is owned by AELIN THERAPEUTICS. The ONCOCOLLAPSE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical drugs based on peptides for treating oncological diseases; peptides as drugs to induce protein aggregation for treating oncological diseases; peptides as drugs to induce protein aggregation resulting in proteostatic collapse for treating oncological diseases

Medical and pharmaceutical research services; pharmaceutical research and development of pharmaceutical products and drugs based on peptides; pharmaceutical research and development of pharmaceutical products and drugs based on protein aggregation stimulating peptides; pharmaceutical research and development of pharmaceutical products and drugs based on aggregation stimulating peptides leading to proteostatic collapse
oncocollapse

General Information


Serial Number79292101
Word MarkONCOCOLLAPSE
Filing DateMonday, June 29, 2020
Status700 - REGISTERED
Status DateTuesday, May 11, 2021
Registration Number6344206
Registration DateTuesday, May 11, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 23, 2021

Trademark Statements


Goods and ServicesPharmaceutical drugs based on peptides for treating oncological diseases; peptides as drugs to induce protein aggregation for treating oncological diseases; peptides as drugs to induce protein aggregation resulting in proteostatic collapse for treating oncological diseases
Goods and ServicesMedical and pharmaceutical research services; pharmaceutical research and development of pharmaceutical products and drugs based on peptides; pharmaceutical research and development of pharmaceutical products and drugs based on protein aggregation stimulating peptides; pharmaceutical research and development of pharmaceutical products and drugs based on aggregation stimulating peptides leading to proteostatic collapse

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 21, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 21, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAELIN THERAPEUTICS
Party Type30 - Original Registrant
Legal Entity Type32 - NOT AVAILABLE
AddressBE

Party NameAELIN THERAPEUTICS
Party Type20 - Owner at Publication
Legal Entity Type32 - NOT AVAILABLE
AddressBE

Party NameAELIN THERAPEUTICS
Party Type10 - Original Applicant
Legal Entity Type32 - NOT AVAILABLE
AddressBE

Trademark Events


Event DateEvent Description
Friday, September 24, 2021NEW REPRESENTATIVE AT IB RECEIVED
Monday, September 20, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, August 26, 2021FINAL DISPOSITION NOTICE SENT TO IB
Thursday, August 26, 2021FINAL DISPOSITION PROCESSED
Wednesday, August 11, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 11, 2021REGISTERED-PRINCIPAL REGISTER
Friday, April 2, 2021NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, February 23, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 23, 2021PUBLISHED FOR OPPOSITION
Wednesday, February 3, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 18, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 15, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 15, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 15, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, November 14, 2020REFUSAL PROCESSED BY IB
Saturday, October 24, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, October 24, 2020REFUSAL PROCESSED BY MPU
Saturday, October 3, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, October 2, 2020NON-FINAL ACTION WRITTEN
Thursday, October 1, 2020ASSIGNED TO EXAMINER
Tuesday, August 25, 2020APPLICATION FILING RECEIPT MAILED
Friday, August 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 20, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB